TAZORAC (Allergan, Inc.)


Welcome to the PulseAid listing for the TAZORAC drug offered from Allergan, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: tazarotene
SUBSTANCE NAME: TAZAROTENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: CUTANEOUS
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-08-01
END MARKETING DATE: 0000-00-00


TAZORAC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTAZORAC from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/g)
START MARKETING DATE: 1997-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-0042_ca6ba093-8b7e-455a-b9ab-74e249420add
PRODUCT NDC: 0023-0042
APPLICATION NUMBER: NDA020600

Other TAZAROTENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.TAZORAC
Mayne Pharma LLCFABIOR
Pacific Pharma, Inc.Tazarotene
Physicians Total Care, Inc.Tazorac
Stiefel Laboratories, Inc.Fabior
Taro Pharmaceuticals U.S.A., Inc.Tazarotene